We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -0.54% | 462.50 | 455.00 | 470.00 | 465.00 | 460.00 | 465.00 | 9,521 | 12:21:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.15 | 219.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/5/2015 09:35 | I would not get too hung up about the share price. This company is the classic example of the action of compound returns within a growing business. The profits being made are clearly being deployed to grow the business further, with cash on the balance sheet. Let the compounding do its work and the share price growth will look after itself. This is a long term hold for very good returns. | rcturner2 | |
21/5/2015 09:32 | over 90p and hold....as a higher low | deanroberthunt | |
21/5/2015 09:26 | At what price would a breakout be? | jimmygee2 | |
21/5/2015 09:14 | 'Organisation dealing well with growth strategy'. Read into that what you like, however would love to believe the're close to announcing how to tackle the U.S. Market. | 2niffy | |
21/5/2015 08:56 | been going sideways now for over a year, could this see it breakout to a new trading level ? | deanroberthunt | |
21/5/2015 08:55 | looks very solid... | deanroberthunt | |
21/5/2015 08:03 | EPS maybe about 4.5p possibly more as profit increase is probably ahead of cost increase. So a PE of about 15 with a 40% increase in profits. | rcturner2 | |
21/5/2015 07:50 | Excellent statement. A very well run successful business with a good record of growth. | rcturner2 | |
21/5/2015 07:39 | Piedro - I have adjusted PBT to remove the share based payments (as per the RNS). In H1 these were £67k. | glaws2 | |
21/5/2015 07:32 | Where does the previously 2.4 forecast come from? From Sharescope, I have FinnCap, confirmed 13/05/15 - £2.30m Equity Development 25/02/15 - £2.32m Consensus ................... £2.31m which makes £2.5+ much better for the bulls | piedro | |
21/5/2015 07:06 | Ahead of expectations trading update. PBT now in excess of £2.5m (previously 2.4 forecast) | glaws2 | |
19/5/2015 17:37 | The FDs Excellence Awards, held in association with ICAEW and supported by the CBI, saw outstanding FDs and financial service providers honoured on 15 May 2015. The Smaller Quoted Finance Director of the Year was Liz Dixon of Tristel. | murray80 | |
13/5/2015 17:25 | Any threat with this one? Kill Microbes on Instruments Cost Effectively with 3M Steri-Vac Sterilizer/Aerator GS Series Recent CRE outbreaks traced to inadequately processed duodenoscopes have highlighted the need for health care facilities to review cleaning and sterilization processes. In the case of a facility in northeastern Illinois, after the hospital changed its reprocessing procedure from automated high-level disinfection to ethylene oxide sterilization, no additional cases of CRE transmission were identified. Ethylene oxide (EO) sterilization provides an overkill sterilization process which means that there is a large safety margin built in to the cycle. For facilities looking for effective reprocessing methods for heat- and moisture-sensitive equipment, the new 3M™ Steri-Vac™ Sterilizer/Aerator GS Series may be the solution. Instruments made of sensitive materials require sterilization solutions that are both budget-friendly and effective at killing microorganisms; sterile processing managers require solutions to help them effectively manage the increasing complexity of instrument reprocessing. .... | piedro | |
11/5/2015 14:18 | I've been rechecking the product lists and it seems that two items have been discontinued ... Tristel Life 5, Life Foam and Life Wipes System Tristel Protect Sporicidal Foam and Bactericidal Wipes | piedro | |
11/5/2015 08:55 | Tristel Rinse Assure case study April 2015 Reducing TVCs down to zero at Neath & Port Talbot Hospital ...Most recent developments are that a third Tristel Rinse Assure system was installed at Moriston Hospital in March 2015. Only three hours after installation, water sample test results showed zero TVCs. Chlorine dioxide was dosed at 0.5ml/L. | piedro | |
07/5/2015 14:22 | Tristel @Tristeluk Going to HFS2015? Steve Wise and Lesley Murray from Tristel will be showcasing our infectioncontrol products. | piedro | |
06/5/2015 04:18 | Tristel @Tristeluk Tristel at the Maltese Infection Control Conference showcasing the Trio Wipe and Stella Systems. | piedro | |
27/4/2015 14:53 | I think one issue for the IT (to which I do not subscribe) is the frequency with which they make tips. Seems like they have to come up with something daily which must make for some fairly duff recommendations. | meijiman | |
27/4/2015 11:17 | IC is a very good magazine, but you have to know where their strengths are. They tip a lot of dross, but they have good coverage of investment trusts for example. Their coverage of mainstream big companies is also good. They have certainly lead me to some very successful investments. | rcturner2 | |
27/4/2015 11:06 | IC became the kiss of death often, hope it isnt the case here...looks interesting. Someone I know in Spain fell off his motorbike and caught mrsa in the hospital here just last year. We dont hear about it too often but its clearly still a problem | elcapital | |
27/4/2015 09:26 | Didn't think the IC would make such a difference. (Read it for 40 years and just watched its decline) Use it for company results and inv funds | petewy | |
27/4/2015 08:38 | Cheers .... ... with plenty of froth. GLA. | piedro | |
27/4/2015 08:29 | I guess the weekend readers of the IC are buying this morning. | rcturner2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions